Kordon E, Lanari C, Mando P, Novaro V, Rossi M, Simian M. The BA-BCS 2021: an initial trial for integrating basic science and medical progress on breast Cancer in a Latin-American country. J Mammary Gland Biol Neoplasia. 2021;26:227–34.

Article  PubMed  PubMed Central  Google Scholar 

Nuckhir M, Withey D, Cabral S, Harrison H, Clarke RB. State of the Art modelling of the breast Cancer metastatic microenvironment: where are we?? J Mammary Gland Biol Neoplasia. 2024;29:14.

Article  PubMed  PubMed Central  Google Scholar 

Parsons J, Harrison H, Kedward T, Fullwood P, Cabral S, Spence K, et al. Proteomics of Patient-derived breast tumours identifies a Pro-migratory Osteomodulin-Cyclin dependent kinase 1 Axis which drives bone metastasis. BioRxiv. 2023. https://doi.org/10.1101/2023.11.03.565489.

Article  PubMed  PubMed Central  Google Scholar 

Schwartz GN, Kaufman PA, Giridhar KV, Marotti JD, Chamberlin MD, Arrick BA, et al. Alternating 17beta-Estradiol and aromatase inhibitor therapies is efficacious in postmenopausal women with advanced Endocrine-Resistant ER + Breast Cancer. Clin Cancer Res. 2023;29:2767–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Traphagen NA, Schwartz GN, Tau S, Roberts AM, Jiang A, Hosford SR, et al. Estrogen therapy induces Receptor-Dependent DNA damage enhanced by PARP Inhibition in ER + Breast Cancer. Clin Cancer Res. 2023;29:3717–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiang WF, Cheng TM, Chang CC, Pan SH, Changou CA, Chang TH, et al. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation. Oncogene. 2018;37:116–27.

Article  CAS  PubMed  Google Scholar 

Gao S, Chen S, Han D, Wang Z, Li M, Han W, et al. Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer. Nat Genet. 2020;52:1011–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Metzger E, Stepputtis SS, Strietz J, Preca BT, Urban S, Willmann D, et al. KDM4 Inhibition targets breast Cancer Stem-like cells. Cancer Res. 2017;77:5900–12.

Article  CAS  PubMed  Google Scholar 

Muralidharan H, Hansen T, Steinle A, Schumacher D, Stickeler E, Maurer J. Breast Cancer stem cells upregulate IRF6 in stromal fibroblasts to induce stromagenesis. Cells. 2024;13:1466.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taifour T, Attalla SS, Zuo D, Gu Y, Sanguin-Gendreau V, Proud H, et al. The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer. Immunity. 2023;12(12):2755–72.

Article  Google Scholar 

Turner NC, Im SA, Saura C, Juric D, Loibl S, Kalinsky K, et al. Inavolisib-Based therapy in PIK3CA-Mutated advanced breast Cancer. N Engl J Med. 2024;391:1584–96.

Article  CAS  PubMed  Google Scholar 

Jhaveri KL, Accordino MK, Bedard PL, Cervantes A, Gambardella V, Hamilton E, et al. Phase I/Ib trial of inavolisib plus Palbociclib and endocrine therapy for PIK3CA-Mutated, hormone receptor-Positive, human epidermal growth factor receptor 2-Negative advanced or metastatic breast Cancer. J Clin Oncol. 2024;42:3947–56.

Article  CAS  PubMed  Google Scholar 

Martino J, Siri SO, Calzetta NL, Paviolo NS, Garro C, Pansa MF, et al. Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells. eLife. 2023;12:e80254.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carbajosa S, Pansa MF, Paviolo NS, Castellaro AM, Andino DL, Nigra AD, et al. Polo-like kinase 1 Inhibition as a therapeutic approach to selectively target BRCA1-Deficient Cancer cells by synthetic lethality induction. Clin Cancer Res. 2019;25:4049–62.

Article  CAS  PubMed  Google Scholar 

Calzetta NL, Gonzalez Besteiro MA, Gottifredi V. Mus81-Eme1-dependent aberrant processing of DNA replication intermediates in mitosis impairs genome integrity. Sci Adv. 2020;6:eabc8257.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Souto EP, Dobrolecki LE, Villanueva H, Sikora AG, Lewis MT. In vivo modeling of human breast Cancer using cell line and Patient-Derived xenografts. J Mammary Gland Biol Neoplasia. 2022;27:211–30.

Article  PubMed  PubMed Central  Google Scholar 

Vaklavas C, Matsen CB, Chu Z, Boucher KM, Scherer SD, Pathi S, et al. TOWARDS study: Patient-Derived xenograft engraftment predicts poor survival in patients with newly diagnosed Triple-Negative breast Cancer. JCO Precis Oncol. 2024;8:e2300724.

Article  PubMed  Google Scholar 

Garcia-Recio S, Hinoue T, Wheeler GL, Kelly BJ, Garrido-Castro AC, Pascual T, et al. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nat Cancer. 2023;4:128–47.

CAS  PubMed  Google Scholar